Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.49 |
| ▸ | CDC25B | P30305 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 8/20 | 0.45 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 6/20 | 0.37 |
| ▸ | CA2 | P00918 | 6/20 | 0.37 |
| ▸ | ATIC | P31939 | 1/20 | 0.36 |
| ▸ | STS | P08842 | 1/20 | 0.36 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13790493 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL10125344 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL9718383 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL9010672 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL14107816 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL10712009 | 1.00 | CDC25A (0.49) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL25314052 | 0.90 | CDC25A (0.53) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL25314057 | 0.90 | CDC25A (0.53) | CDC25ACDC25BNR1H4CYP24A1CA1 | |
| SCHEMBL10041403 | 0.88 | NR1H4 (0.42) | CDC25ACDC25BNR1H4CYP24A1ATIC | |
| SCHEMBL10041413 | 0.88 | NR1H4 (0.42) | CDC25ACDC25BNR1H4CYP24A1ATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2556054-B1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | WISCONSIN ALUMNI RES FOUND (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2556053-B1 | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1ALPHA,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1ALPHA,25-HYDROXYVITAMIN D3 | WISCONSIN ALUMNI RES FOUND (US) | 2015-07-29 | — | — | EP | disclosed |
| US-8664206-B2 | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-03-04 | — | — | US | disclosed |
| US-20120165300-A1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-06-28 | — | — | US | disclosed |
| US-20120165300-A1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-06-28 | — | — | US | disclosed |
| US-20110237557-A1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2011-09-29 | — | — | US | disclosed |
| US-20110237556-A1 | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2011-09-29 | — | — | US | disclosed |
| US-20110237556-A1 | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2011-09-29 | — | — | US | disclosed |
| WO-2011119610-A2 | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165300-A1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | CYP24A1, CYP2R1, CYP27B1 | CDC25A 1007/4885CDC25B 965/4885NR1H4 119/4885 |
| US-20110237557-A1 | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | CYP24A1, CYP2R1, CYP27B1 | CDC25A 1007/4885CDC25B 965/4885NR1H4 119/4885 |
| US-20110237556-A1 | (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 | CYP24A1, CYP27B1, CYP2R1 | CDC25A 1132/4885CDC25B 906/4885NR1H4 188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.